学术经纬

美国圣裘德儿童医院马佩君课题组招聘博士后

Image

▎药明康德内容团队编辑

Join Dr. Peijun Ma’s Lab at St. Jude Children’s Research Hospital (Memphis, TN, U.S.)

We are expanding rapidly and seeking passionate, self-driven postdoctoral researchers and graduate students to join our team. With exceptional research resources and funding support, our lab focuses on applying cutting-edge bacterial single-cell genomics and transcriptomics to tackle antibiotic resistance and persistence in bacterial pathogens. 

More details can be found here:

https://www.stjude.org/directory/m/peijun-ma.html

Our Research Focus: We push the boundaries of microbial single-cell sequencing to explore how bacterial populations develop drug resistance and persistence. By profiling drug-induced heterogeneity at the single-cell level, we aim to uncover novel resistance mechanisms and identify potential new therapeutic targets.

Key Areas of Research:

• Investigating drug-induced bacterial heterogeneity and its impact on resistance and persistence.

• Exploring bacterial intrinsic heterogeneity, including cell cycles and cell-to-cell communication, in the development of resistance.

• Characterizing the microbiome using cutting-edge single-cell genomic and transcriptomic approaches.

Preferred Qualifications:

• Background in molecular biology, microbiology, microbiome research, or related fields.

• Experience with next-generation sequencing and computational skills is a plus but not required.

Why Join Us?

• Be part of groundbreaking research in single-cell microbiology with access to advanced technologies.

• Gain experience in both wet-lab and dry-lab skills in next-generation and third-generation sequencing.

• Collaborate with experts at a world-renowned research institution equipped with state-of-the-art core facilities.

How to Apply: Please submit your cover letter, CV, and contact information for three references to Dr. Peijun Ma ([email protected]). 

本文来自药明康德内容微信团队,欢迎转发到朋友圈,谢绝转载到其他平台。如有开设白名单需求,请在“学术经纬”公众号主页回复“转载”获取转载须知。其他合作需求,请联系[email protected]。

免责声明:药明康德内容团队专注介绍全球生物医药健康研究进展。本文仅作信息交流之目的,文中观点不代表药明康德立场,亦不代表药明康德支持或反对文中观点。本文也不是治疗方案推荐。如需获得治疗方案指导,请前往正规医院就诊。